BMS-202 T3146
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
PD1-PDL1 inhibitor 2 is an inhibitor of the PD-1 (Programmed death- 1) /PD-Ll (Programmed death-ligand 1) protein/protein interaction, extracted from patent WO/2015034820 A1.
CAS nr:
1675203-84-5
Purity:
98%
Molecular Weight:
419,52
SMILES:
Cc1c(cccc1COc1nc(c(cc1)CNCCNC(=O)C)OC)c1ccccc1
Formula:
C25H29N3O3
Pathway:
Apoptosis,Immunology/Inflammation,Cell Cycle/Checkpoint,Apoptosis
Target:
PD-1/PD-L1,PD-1/PD-L1,PD-1/PD-L1,Apoptosis
